ProCE Banner Series

Optimizing Asparaginase Therapy: Navigating Evolving Clinical Challenges in Pediatric and AYA ALL for Improved Outcomes 

Join us in-person or virtually for this satellite symposium that will provide expert perspectives on how to optimize clinical outcomes with the use of asparaginase-based therapy for pediatric and adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL), including information on evidence-based strategies to effectively prevent, mitigate, and manage the associated adverse events in the personalization of patient care.

  AMA
Who Should Attend

This activity is intended for pediatric oncologists and other healthcare professionals caring for children, adolescents, and young adults with ALL.

All Events

Optimizing Asparaginase Therapy: Navigating Evolving Clinical Challenges in Pediatric and AYA ALL for Improved Outcomes 

Upcoming Events

May

07

2025

5:30 PM - 7:30 PM Eastern Time (ET)

In-person

Kentucky International Convention Ctr, 221 S 4th Street, Louisville, Kentucky 40202

6:00 PM - 7:30 PM Eastern Time (ET)

Virtual

Topics

Asparaginase-Based Regimens for Pediatric and AYA Patients With ALL

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve learners’ knowledge, confidence, and competence in managing the treatment of patients with ALL, including asparaginase therapies.

Target Audience
This activity is intended for pediatric oncologists and other healthcare professionals caring for children, adolescents, and young adults with ALL.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Discuss current efficacy evidence and unmet needs related to the optimized use of asparaginase in pediatric ALL, including the role of novel Erwinia asparaginase compounds

  • Devise strategies to address therapeutically relevant considerations related to asparaginase use for pediatric ALL such as appropriate dosing, pre-empting truncation/discontinuation, and drug-related toxicity

  • Implement monitoring protocols to identify hypersensitivity, silent inactivation, or toxicity in pediatric ALL and increase completion rates of asparaginase treatment 

  • Evaluate current clinical evidence and expert recommendations for implementing pediatric-inspired therapeutic regimens for ALL into treatment plans for adolescents and young adults, understanding the place in therapy of asparaginase regimens in an evolving clinical landscape

Accreditation

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/67167f3d10da3.png

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through CCO's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by an educational grant from Jazz Pharmaceuticals, Inc.